Together, these results not only provide key insights into the pathological mechanisms underlying MSA prion propagation in a valuable mouse model for drug discovery programs focused on α-synuclein prions, but also shed light on the clinical manifestations of disease pathogenesis in MSA patients. Here, SNCA is linked to multiple system atrophy.